2018 AIChE Annual Meeting
(188ag) Yeast Hydrolysate Fractions and the Impact on Monoclonal Antibody Production
Authors
We implemented a systematic approach to identify components in yeast hydrolysate with the goal of identifying components that contribute the most to cell culture performance. Crude yeast hydrolysate was first separated by ultrafiltration into permeate and retentate fractions (Fractionation 1), using a 3kDa MWCO filter. Screening of Fractionation 1 in cell culture suggests that yeast hydrolysate components < 3kDa improve titer by 10% while maintaining similar cell growth. Through transcriptomics studies, we further characterized the production hostâs response to yeast hydrolysate and Fractionation 1 to gain a better understanding of how these fractions impact CHO cell metabolism and monoclonal antibody production. In parallel, reverse phase HPLC (RP-HPLC) was used to further separate Fractionation 1 of < 3kDa through multiple rounds of fractionation. The latest fraction retains 6.8% of the original hydrolysate content while improving titer by > 15%. Further screening by mass spectrometry provided peptide profiling of these fractions, which will aid our efforts towards developing a CD âhydrolysateâ feed inclusive of peptides that provide the highest metabolic potential to CHO cells.